Tumgik
#Pharmaceutical market
mukulsoni1 · 2 months
Text
Innovation in Wellness: Exploring the Trends of the Pharmaceutical Industry
Tumblr media
Delve into the healthcare catalysts within the Pharmaceutical Sector. Gain valuable insights into the sector's dynamics, advancements, and contributions to the well-being of individuals worldwide
0 notes
medi-techinsights · 9 months
Text
African Pharmaceutical Market is set to witness a significant growth rate by 2027
The pharmaceutical market is a very complex but an emerging market which plays a key role in the growth of the healthcare segment. The pharmaceutical market refers to the market for pharma and medical products, which includes prescription drugs, over-the-counter medications, generic drugs and other healthcare products.
Emerging Growth Opportunities in African Pharmaceutical Market
The pharmaceutical market in Africa is very less developed as compared to the other regions such as North America, Middle-East, Europe, Asia-Pacific, which further makes it a potentially attractive market for new investment opportunities. The African pharmaceutical market is growing rapidly, along with producing many investment and growth opportunities for healthcare companies.
Africa's fast urbanization is further driving the growth for key pharmaceutical companies. With the emergence of metro and tier-1 cities and growing awareness of many health disorders such as diabetes, ADHD, and malaria, there has been a sudden growth in the purchase of terminal disease medications and healthcare costs. Governments are updating their policies to attract foreign investors and leading healthcare companies which is thus leading to an emerging commercial landscape in Africa.
Emerging Shift towards a Western lifestyle in Africa has caused a rapid surge in the non-communicable diseases (NCDs), thus leading for a high demand for chronic prescription drugs. Governments in many African countries are making efforts to enhance their healthcare infrastructures and provide easy access to medicines, which is anticipated to boost the growth of the African pharmaceutical market. Rapid adoption of generic drugs and the growth of e-commerce in the African region are also projected to contribute to the growth of the African pharmaceutical market. 
Tumblr media
Positive Market Dynamics and Upcoming Growth Opportunities for Pharma Companies in the African Pharmaceutical Market
Covid-19 Pandemic has shed light on the vulnerability of the healthcare systems and focused on the importance of regions ensuring a basic level of supply security for medical products. Daily drugs and medicines are not easily available in Africa as it depends on imports mostly, with up to 70% of pharmaceutical products being imported from developed regions.
The pharmaceutical market in Africa is divided into three primary categories: prescription drugs, generics drugs, and over-the-counter drugs. Generics have experienced the highest and quickest growth. Production of generics provides a best chance for the private companies to increase their investments and enrich their overall capabilities.
Global healthcare companies need to partner with local enterprises and governments to enhance their chances of success in the pharmaceutical market. Working together on research, public awareness campaigns and medical device provision can help dominate the African pharmaceutical market in their favor.
Upcoming Market Challenges: African Pharmaceutical Market
Africa's pharmaceutical market suffers from many challenges, which includes small and fragmented markets, weak regulatory frameworks, and inadequate manpower capacity. Poor procurement and supply chain systems, as well as policy incoherencies across trade, market, health, and finance market, and lack of funds for R&D activities also affects the growth of the African pharmaceutical market.
Competitive Landscape Analysis: African Pharmaceutical Market
Some of the established players operating in the African pharmaceutical market are Adcock Ingram, F. Hoffmann-La Roche, Pfizer Inc., Novartis AG, Johnson & Johnson (Janssen Global Services LLC), Sanofi, Bayer, Aspen, Cipla, and Merck and Co. Inc..
The African pharmaceutical market is expected to witness a healthy growth in the coming years due to the rapidly growing African population, growing demand for generic drugs, rising cases of chronic diseases and positive government initiatives to enhance easy access to medicines and efficient growth strategies adopted by the key players operating in the African pharmaceutical market.
Get Detailed Insights on African Pharmaceutical Market with a FREE Sample Report @ https://meditechinsights.com/african-pharmaceutical-market/
0 notes
Text
The global pharmacogenomics market is expected to grow significantly over the forecast period. This is due to the growing demand for personalized medicine, advancements in genetic research, and the increasing incidence of chronic diseases. The rise in genetic tests and growing awareness about pharmacogenomics among healthcare professionals and patients are also contributing to the market growth.
0 notes
freyrsolutions · 1 year
Text
0 notes
pharmasolutions · 1 year
Text
Did You Know?
0.5-1% of breast cancers occur in men.
Breast cancer can affect men too! Although rare, men too can get breast cancer, contrary to the widespread notion that this form of cancer only affects women.
According to Globocan 2020 report, breast cancer is the most commonly diagnosed cancer in females and males, about 21.4%. Additionally, it affected 38.8% of females of all ages in the UAE in 2020.
October is designated as the Pink month of support and awareness about breast cancer. Dedicated to those affected by this deadly disease, the world comes out to show solidarity with everyone impacted.
In 2020, nearly 2.3 million women were diagnosed with breast cancer worldwide, and an estimated 685000 people lost their lives due to this deadly disease. 
Let’s take a look at all the breast cancer symptoms.
0 notes
Last week, Johnson & Johnson agreed not to enforce their secondary patents on bedaquiline in most countries after a long public pressure campaign by TB activists around the world.
(A special shoutout to Nandita Venkatesan and Phumeza Tisilethe, the two women who led the charge to prevent the patent evergreening in India, which is the only reason generic bedaquiline is in production.)
But the problem of patent evergreening is everywhere--as this NYT story reports, Gilead intentionally denied people access to a drug they knew to be less toxic than alternatives because it wanted to extend its monopoly on HIV drugs for as long as possible.
Similarly, Johnson & Johnson has been intentionally denying people access to affordable bedaquiline, even though they knew they could make a profit even if they decreased the price by 65%.
What's especially galling is that both these companies benefit tremendously from public investment (bedaquiline research was funded primarily by the public), and so we end up paying for it twice--once to develop it, and once to have it available to the sick.
This is infuriating, and it is resulting in the real impoverishment and death of so many people. How does it end? With better governance and regulation. In this respect, India can be a model for us--their courts have done a much better job than U.S. ones of determining what really deserves to be patented and for how long. I'm hopeful that we can learn from the, but disgusted by this ongoing horror.
1K notes · View notes
magnetothemagnificent · 2 months
Text
What is it with this new framing by drug companies of gastrointestinal issues as "just girly things"???? Like. I spent last week with my grandparents which meant that live TV was on in the background at nearly all waking hours and the amount of commercials I've seen, from laxative companies to nutritional supplement companies framing chronic constipation, bloating, and other GI issues as just little things that happen when you're a woman. There was one commercial where this woman was like (paraphrased) "I get constipated a lot, like most women do". Also framing constipation as just making you feel 'heavy' and encouraging laxative and supplement use to feel 'lighter'. Chronic constipation isn't about feeling 'heavy'! It's got nothing to do with how you feel! It's often a symptom of an underlying GI disorder and not just a feeling oh my god.
Ladies. It is not a normal part of womanhood to be experiencing chronic GI issues. Talk to your doctor. Don't listen to these companies telling you to just treat yourself with OTC solutions and that your very real issues are just 'feeling heavy'. Oh my god. As someone who actually has these issues this is infuriating.
78 notes · View notes
is-this-really--life · 8 months
Text
The fact that we can all agree that something big happened in 2015 culturally around gender and feminism but no one can agree on what the fuck caused it
35 notes · View notes
thoughtportal · 1 year
Video
a very good video “this you?”
https://en.wikipedia.org/wiki/Diana_Harshbarger
https://www.businessinsider.com/diana-harshbarger-congress-stocks-violation-stock-act-trades-tennessee-2021-8?op=1
https://www.safemedicines.org/2013/05/tennessee-pharmacist-pleads-guilty-to-selling-misbranded-kidney-dialysis-drug-536.html
61 notes · View notes
littlefleamart · 8 months
Text
Tumblr media
(source)
12 notes · View notes
mukulsoni1 · 3 months
Text
Navigating Opportunities in the Pharmaceutical Market
Tumblr media
Gain valuable insights into the Pharmaceutical Market Future Outlook, shaping the future of healthcare. Uncover trends, advancements, and strategic opportunities that define success in this ever-evolving industry
0 notes
alientitty · 9 months
Text
anyone else bothered by how common it is these days to reduce the complexity of human emotions to a neurotransmitter or two...
2 notes · View notes
gaykey · 1 year
Text
also, people in the us....the length of your adverts/commercials are ridiculous, and they are all for drugs????
8 notes · View notes
delvens-blog · 11 months
Text
The global market for Pharmaceutical Packaging is expected to reach $122.6 billion by 2030 from $109.4 billion in 2022, registering impressive expansion at a compound annual growth rate (CAGR) of 6.7%. Some of the major players are Amcor Ltd., Becton, Dickinson, Aptargroup, Inc., Capsugel Inc., Gerresheimer AG, Schott AG, Terumo Corporation, WEST Pharmaceutical Services, Inc., Berry Plastics Group, Inc., Westrock Company, SGD SA, Comar LLC, International Paper Company, Owens Illinois Inc., Aptar Group Inc.
2 notes · View notes
pcdpharmafranchise · 1 year
Text
Tumblr media
Hi-Cure Biotech is one of the India's best PCD Pharma Franchise Company. We deal in wide range of pharma products at Low investment & High profit. Offering Pharma Franchise in India for more enquire :
Contact us : +91-9023639358 Email Id : [email protected] Visit : www.hicurebiotech.com
2 notes · View notes
boeing747 · 1 year
Note
what book is it that you're reading?
empire of pain by patrick radden keefe! its honestly a really fun read so far it's only making me mildly furious but i suspect that'll change
4 notes · View notes